Cargando…
Adropin protects against liver injury in nonalcoholic steatohepatitis via the Nrf2 mediated antioxidant capacity
Adropin, a secretory signal peptide, has shown beneficial effects on improving glucose homeostasis and dyslipidemia. However, whether this peptide affects nonalcoholic steatohepatitis (NASH) has remained unclear. In this study, the serum adropin levels, liver injury and oxidative stress were measure...
Autores principales: | Chen, Xu, Xue, Hongliang, Fang, Wanjun, Chen, Ke, Chen, Shen, Yang, Wenqi, Shen, Tianran, Chen, Xuechen, Zhang, Peiwen, Ling, Wenhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6351233/ https://www.ncbi.nlm.nih.gov/pubmed/30684890 http://dx.doi.org/10.1016/j.redox.2018.101068 |
Ejemplares similares
-
Antioxidant Therapy in Nonalcoholic Steatohepatitis
por: Al-Busafi, Said A., et al.
Publicado: (2012) -
Association of sex hormone-binding globulin with nonalcoholic fatty liver disease in Chinese adults
por: Luo, Jing, et al.
Publicado: (2018) -
Taurine and tea polyphenols combination ameliorate nonalcoholic steatohepatitis in rats
por: Zhu, Wenhua, et al.
Publicado: (2017) -
Nonalcoholic steatohepatitis severity is defined by a failure in compensatory antioxidant capacity in the setting of mitochondrial dysfunction
por: Boland, Michelle L, et al.
Publicado: (2018) -
Dapagliflozin protects against nonalcoholic steatohepatitis in db/db mice
por: Qiao, Panshuang, et al.
Publicado: (2022)